FGF2 and neoplasm: Propranolol reduces the vascular flow to the tumor via β2 adrenergic receptor by vasoconstriction (69) and downregulates factors promoting tumoral growth such as HIF-1α, metalloprotease, basic fibroblast growth factor (bFGF), and vascular endothelial growth factor (VEGF).